EpiPen maker Mylan is racing to put down a revolt from shareholders outraged by a $98 million pay package for its former CEO.
http://money.cnn.com/2017/06/13/investing/epipen-mylan-exec-pay-shareholder-revolt/index.html
EpiPen maker Mylan is racing to put down a revolt from shareholders outraged by a $98 million pay package for its former CEO.
http://money.cnn.com/2017/06/13/investing/epipen-mylan-exec-pay-shareholder-revolt/index.html